Table 1. Demographic characteristics of the patient population in the dataset.
| Cancer site | Number diagnosed (n) | n (%)* with symptoms | n (%)** with NICE symptoms | Age at diagnosis | n (%)*** females | ||
|---|---|---|---|---|---|---|---|
| Median | Mean | SD | |||||
| Bladder | 2210 | 1519 (68.7) | 1299 (85.5) | 74 | 73.5 | 10.4 | 395 (26.0) |
| Breast | 3147 | 1620 (51.5) | 1316 (81.2) | 66 | 67.1 | 13.3 | 1620 (100) |
| Cervix | 421 | 150 (35.6) | 68 (45.3) | 57 | 59.4 | 14.9 | 150 (100) |
| Colorectal | 6557 | 4363 (66.5) | 2508 (57.5) | 73 | 72 | 11.2 | 1984 (45.6) |
| Gastric | 2021 | 1118 (55.3) | 1002 (89.6) | 74 | 72.9 | 10.8 | 397 (35.5) |
| Head and Neck | 612 | 328 (53.6) | 282 (86.0) | 69 | 67.9 | 12.3 | 68 (20.7) |
| Kidney | 1467 | 503 (34.3) | 272 (54.0) | 70 | 68.7 | 11.4 | 172 (34.2) |
| Leukaemia | 1961 | 383 (19.5) | 370 (96.6) | 72 | 70.7 | 11.9 | 185 (48.3) |
| Lung | 6552 | 4253 (64.9) | 3816 (89.7) | 73 | 72.1 | 10.3 | 1821 (42.8) |
| Lymphoma | 2232 | 685 (30.7) | 652 (95.2) | 70 | 68.8 | 12 | 343 (50.1) |
| Myeloma | 1158 | 500 (43.2) | 497 (99.4) | 72 | 71.4 | 10.8 | 218 (43.6) |
| Oesophageal | 1842 | 1389 (75.4) | 1314 (94.6) | 72 | 71.0 | 11.1 | 464 (33.4) |
| Pancreatic | 1370 | 946 (69.1) | 859 (90.8) | 73 | 71.9 | 11.7 | 505 (53.4) |
| Testicular | 161 | 104 (64.6) | 68 (65.4) | 47 | 50.8 | 10.5 | 104 (100) |
| Endometrial | 1297 | 757 (58.3) | 571 (75.4) | 66 | 66.9 | 10.9 | 757 (100) |
| Pooled | 33008 | 18618 (56.4) | 14894 (80.0) | 72 | 70.6 | 11.7 | 6552 (41.0) |
* Number of with symptoms as a fraction of the number with cancer diagnosis
**Number with NICE symptoms as a fraction of the number with symptoms (fraction of those analysed)
*** Number of females as a fraction of the number with symptoms (fraction of those analysed).